Skip to main content
Equibles

China Universal Asset Management Co., Ltd.

Position in NBIX — Neurocrine Biosciences Inc

CIK 1906594 SHANGHAI, F4
Back to NBIX Full portfolio

Position in NBIX

as of Jun 30, 2026 · filed Jul 24, 2026
Position Value
$2,697,145
+$350,856 QoQ
Shares Held
16,003
-10.1% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#280
of 774 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

China Universal Asset Management Co., Ltd. holds $16,477,419 across 28 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (16.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 6,755 $3,660,061
2 VTRS
Viatris Inc
 185,339 $2,943,183
3 NBIX
Neurocrine Biosciences Inc
This page 		16,003 $2,697,145
4 ALKS
Alkermes plc.
 26,527 $1,389,882
5 AMRX
Amneal Pharmaceuticals, Inc.
 50,773 $878,880
6 INDV
Indivior Pharmaceuticals, Inc.
 19,404 $796,146
7 KNSA
Kiniksa Pharmaceuticals International, plc
 7,369 $471,247
8 SUPN
Supernus Pharmaceuticals, Inc.
 9,237 $429,612

All Filings in NBIX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,697,145 16,003
2026-03-31 $2,346,289 17,810
2025-12-31 $2,304,312 16,247
2025-09-30 $2,440,506 17,385
2025-06-30 $2,498,340 19,877
2025-03-31 $2,211,889 19,999
2024-12-31 $2,930,382 21,468
2024-09-30 $2,237,687 19,421
2024-06-30 $1,627,810 11,824
2024-03-31 $2,640,892 19,148
2023-12-31 $1,497,320 11,364
2023-09-30 $281,700 2,504
2023-06-30 $120,609 1,279
2023-03-31 $132,496 1,309
2022-12-31 $116,692 977
2022-09-30 $95,164 896